ScholarLens Back to search
2013•Open Repository and Bibliography (University of Liège)Open access

Eculizumab (ECU) Inhibits Thrombotic Microangiopathy (TMA) and Improves Renal Function in Adult Atypical Hemolytic Uremic Syndrome (aHUS) Patients (Pts)

Fádi Fakhouri, Maryvonne Hourmant, Josep M. Campistol, Spero Cataland, Mario Espinosa, Osama Gaber, Jan Menne, Enrico Minetti, François Provôt, Éric Rondeau, Piero Ruggenenti, Laurent Weekers, Masayo Ogawa, Camille L. Bedrosian, Christophe Legendre

Open full text 9 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Thrombotic microangiopathy, Atypical hemolytic uremic syndrome, Eculizumab, Medicine, Renal function, Internal medicine, Gastroenterology, Immunology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Eculizumab (ECU) Inhibits Thrombotic Microangiopathy (TMA) and Improves Renal Function in Adult Atypical Hemolytic Uremic Syndrome (aHUS) Patients (Pts) — Research Paper | ScholarLens